Table 4.

Predictors of pathological c-IMT (≥0.90 mm). Univariate analysis.

	Subjects with c-IMT≥0.90 mm (n = 195) OR (CI%95)	p-value
Age (years) ≥ 65	4.41 (3.07–6.34)	< 0.001
Men (%)	1.92 (1.35–2.74)	< 0.001
Non–smokers	0.82 (0.57–1.17)	0.276
Current Smokers (%)	1.00 (0.64–1.55)	0.986
Ex–smokers (%)	1.18 (0.85–1.63)	0.318
Hypertension (%)	3.47 (2.32–5.20)	< 0.001
Dyslipidemia (%)	0.49 (0.50–1.25)	0.329
Diabetes (%)	2.34 (1.68–3.28)	< 0.001
Obesity (%)	1.10 (0.79–1.52)	0.553
Sedentary (%)	0.92 (0.65–1.30)	0.660
Metabolic Syndrome (%)	3.06 (2.19–4.28)	< 0.001
CV event (%)	3.08 (2.18–4.34)	< 0.001
SBP (mmHg) ≥ 140	1.77 (1.27–2.46)	0.001
DBP (mmHg) ≥ 90	0.55 (0.35–0.85)	0.008
PP (mmHg) ≥ 60	3.19 (2.26–4.49)	< 0.001
TC (mg/dL) ≥ 190	0.57 (0.39–0.83)	0.004
LDL (mg/dL) ≥ 100	0.52 (0.37–0.74)	< 0.001
Triglyceride (mg/dL) ≥ 200	0.82 (0.52–1.30)	0.416
FPG (mg/dL) ≥ 126	1.63 (1.11–2.40)	0.013
HbA1C (%) ≥ 6.5	1.63 (1.11–2.40)	0.011
eGFR (ml/min) < 60	1.54 (1.06–2.25)	0.023
Antihypertensive drugs	5.09 (3.08–8.41)	< 0.001
Lipid lowering drugs	1.26 (0.79–2.01)	0.321
Antidiabetic drugs	1.89 (1.36–2.63)	< 0.001

CV, cardiovascular; DBP: Diastolic Blood Pressure; FPG, fast plasma glucose; HbA1c, glycated hemoglobin; HDL, high–density lipoprotein; LDL, low–density lipoprotein; PP, pulse pressure; SBP, systolic blood pressure; TC, total cholesterol. Bold means statistically significant values.